Home » HSI, Partners Seize $3.9M in Counterfeit Pharmaceuticals
HSI, Partners Seize $3.9M in Counterfeit Pharmaceuticals
Special agents with U.S. Immigration and Customs Enforcement's (ICE) Homeland Security Investigations (HSI), working jointly with the South Carolina Secretary of State's Office, Blazer Investigations and Pfizer, seized approximately $4 million in counterfeit goods and pharmaceuticals during a two-week operation that ran from Feb. 19 through Wednesday.
"The illegal importation and sale of counterfeit goods is a significant problem that affects our economy, impacts American jobs and innovation, puts the public's health and safety at risk, and at times, threatens our national security," said Brock D. Nicholson, special agent in charge for HSI Atlanta. "Consumers should know that if they buy pirated, counterfeit and/or unlicensed products, they are hurting legitimate businesses, and they may also be facilitating criminal activity. Imposter drugs like those seized during this operation pose a serious threat to buyers who mistakenly assume these substances are safe."
Counterfeit merchandise is a lose-lose situation, harming those retailers who play by the rules and cheating consumers out of the quality products they need or deserve," said South Carolina Secretary of State Mark Hammond. "Fake medicine takes this harm to another level because it can literally kill you. Consumers need to be aware that just because a counterfeit pill looks like a name-brand product, the chemicals and by-products it contains may be dangerous to ingest. Passing off so-called 'pharmaceuticals' as a cheap alternative to name-brand medicine is a prescription for disaster. I am very pleased that these fakes are off of our streets."
During the two-week operation, HSI special agents and partner law enforcement officers seized approximately $3.6 million in counterfeit pharmaceuticals including Viagra, Cialis and Proscar shipped from India to a warehouse in Columbia. The operation also netted the seizure of more than $290,000 of counterfeit and pirated goods infringing on trademarked brands like Coach, Prada, Ray Ban, Golf Pride and TaylorMade. Allegedly, the counterfeit and pirated goods were shipped from China to the same reshipping warehouse in Columbia. The total manufacturer's suggested retail value of the seized goods is approximately $3.9 million.
As the largest investigative arm of the Department of Homeland Security, HSI plays a leading role in targeting criminal organizations responsible for producing, smuggling and distributing counterfeit products. HSI investigations focus not only on keeping counterfeit products off U.S. streets, but also on dismantling the criminal organizations behind such activity.
This investigation was supported by the HSI-led National Intellectual Property Rights (IPR) Coordination Center in Washington. The IPR Center is one of the U.S. government's key weapons in the fight against criminal counterfeiting and piracy. As a task force, the IPR Center uses the expertise of its 21-member agencies to share information, develop initiatives, coordinate enforcement actions and conduct investigations related to IP theft. Through this strategic interagency partnership, the IPR Center protects the public's health and safety and the U.S. economy.
For more information on the IPR Center, please visit www.IPRCenter.gov.
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
$15 Billion Myland Offer Rejected By ActavisFrom Bloomberg.com
Actavis has rejected drugmaker Mylan Inc's cash-and-stock offer for $15 billion. They have decided to continue talks to take over Warner Chilcott Plc instead, sources have said.
- All news »
- Popular Articles
- Newest Articles
- Popular Downloads
- Featured White Papers